Mounting, Debt

Mounting Debt and Legal Challenges Weigh on Oracle’s Stock

21.01.2026 - 10:26:04

Oracle US68389X1054

Oracle Corporation finds itself navigating turbulent waters as a combination of legal action, escalating debt concerns, and scrutiny over its artificial intelligence strategy pressures its share price. The stock has shed nearly half its value since reaching a peak in September 2025, including a decline of approximately 6% this week alone.

A significant factor in the recent sell-off is a class-action lawsuit filed in a New York court. The Ohio Carpenters' Pension Plan alleges that Oracle misled bond investors regarding the capital requirements for its AI expansion.

The legal complaint centers on a bond issuance worth roughly $18 billion at the end of September. This fundraising occurred just weeks after Oracle announced a potentially $300 billion five-year contract with OpenAI. Plaintiffs argue the company failed to adequately disclose how much additional debt would be necessary to fulfill such substantial commitments.

Key allegations from bondholders include:
* Inadequate transparency regarding future financing needs.
* Insufficient disclosure of costs associated with AI infrastructure build-out.
* Elevated risk of rising capital costs within a high-interest-rate environment.

Diverging Estimates on Future Capital Requirements

The lawsuit has intensified focus on Oracle's balance sheet. Analyst projections for the company's future funding needs vary widely:
* BNP Paribas estimates an additional $25 to $30 billion will be required.
* Other market researchers warn the total need could reach $70 billion by 2026.
* In a climate of persistently higher interest rates, the associated debt-servicing costs would also rise significantly.

Oracle currently reports a debt-to-equity ratio of 0.24 and a cash ratio of 0.1. Metrics once viewed as signs of a solid financial foundation are now being reassessed more critically.

Should investors sell immediately? Or is it worth buying Oracle?

Free Cash Flow Turns Deeply Negative

Operationally, Oracle's performance remains robust. Quarterly revenue grew 14% year-over-year, with cloud services and application revenue advancing more than 30%. However, the company's free cash flow has deteriorated sharply, turning negative to the tune of over $13 billion.

This presents a growing problem for investors. In the current market climate, growth alone is insufficient. Without a clear path to generating liquidity and stabilizing its balance sheet, justifying a premium valuation becomes increasingly difficult.

Broader Trade Policy Adds to Sector Pressure

Announced U.S. tariffs on European imports further cloud the outlook. Import duties of 10% are set to take effect on February 1, with the potential for these to rise to 25% should negotiations concerning Greenland fail. This policy uncertainty is causing unease across the broader technology sector.

Bullish Case Hinges on OpenAI Partnership

Despite the headwinds, some analysts maintain a positive outlook. Guggenheim analyst John DiFucci has named Oracle his top recommendation for 2026, reiterating a price target of $400—more than double the current trading level.

DiFucci forecasts Oracle's revenue will surge to $228 billion by 2030, up from an estimated $67 billion in 2026. He contends the company's "Bring-Your-Own-Chip" model could cap the actual capital requirement below $100 billion, as customers would contribute their own GPUs. OpenAI currently represents about 60% of Oracle's remaining performance obligations, equating to approximately $315 billion in future business. DiFucci projects revenue from the OpenAI partnership will grow from $3.6 billion in fiscal 2026 to $62.4 billion by 2030.

Technical Analysis Points to Continued Weakness

From a chart perspective, Oracle's shares are trading well below key moving averages at €165.90. This price represents a decline of roughly 49% from the 52-week high of €280.70 reached in September. A sustained break below current support levels would shift focus toward the €150 mark, with a potential retreat toward the April lows near €111 remaining a risk in a more extreme scenario.

Ad

Oracle Stock: Buy or Sell?! New Oracle Analysis from January 21 delivers the answer:

The latest Oracle figures speak for themselves: Urgent action needed for Oracle investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from January 21.

Oracle: Buy or sell? Read more here...

@ boerse-global.de | US68389X1054 MOUNTING